Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL

NCT04846439 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Platelet Transfusion Refractoriness
Acute Leukemia in Remission

Interventions

BIOLOGICAL: CAR-T infusion

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]